Billy Evans, the partner of Elizabeth Holmes, has launched a secretive blood-testing startup called Haemanthus that utilizes laser technology and AI to pursue radical health diagnostics.
Key Points
- Haemanthus is developing a diagnostic device that uses Raman spectroscopy to analyze blood, saliva, and urine samples for human health optimization.
- The company is currently bypassing FDA oversight by conducting initial testing on animals under Department of Agriculture regulations.
- Evans has raised approximately $18.15 million in funding, including $3.15 million from friends and family and $15 million from institutional investors.
- The startup aims to shrink its diagnostic technology into a wearable device, projecting a three-year development timeline and a $70 million budget.
- Despite public speculation linking the venture to Theranos, Haemanthus maintains that Elizabeth Holmes has no formal involvement in the company.